BIOS Fund I LP 13D/13G Filings for Actuate Therapeutics Inc (ACTU)

BIOS Fund I LP 13D and 13G filings for Actuate Therapeutics Inc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-08-19
8:59 pm
Purchase
2024-08-14 13D Actuate Therapeutics Inc
ACTU
BIOS Fund I LP 10,125,488
52.800%
10,125,488increase
(New Position)
Filing